IRCT20121231011956N10.
Trial name or title | Comparison of the effectiveness of haloperidol and quetiapine for delirium in the emergency department and intensive care unit |
Methods | Single‐site, double‐blind, randomized study taking place in Iran. Target enrolment: 100 participants |
Participants | Adult (> 18 years) patients admitted to the Emergency Department or ICU and diagnosed with delirium via DSM criteria |
Interventions | Participants randomized to receive haloperidol (5 mg IM daily) or quetiapine (25 mg PO daily) |
Outcomes |
Primary
Secondary
|
Starting date | March 2018 |
Contact information | Morteza Talebi Doluee (talebidm@mums.ac.ir) |
Notes | Study recruitment is complete Funding source: Mashhad University of Medical Sciences Sponsor: Mashhad University of Medical Sciences Study registered: at https://en.irct.ir/trial/29718 |